Indications |
Oral Pain and irritability in cystitis, prostatitis and urethritis Adult: As hydrochloride: 200 mg tid. When combined with an antibiotic, max duration of treatment is 2 days, although lower doses for at least a wk have been given. Child: As hydrochloride: 12 mg/kg/day in 3 divided doses for 2 days.
|
||||||
Contraindications |
Impaired renal function or severe hepatitis. CrCl <50 ml/min. | ||||||
Warnings / Precautions |
Avoid prolonged use. Pregnancy and lactation. G6PD deficiency. Stop treatment if skin or sclerae discolouration occur. Elderly. | ||||||
Adverse Reactions |
GI disturbances, headache; rash; hepatotoxicity; haemolytic anaemia, methaemoglobinaemia; discolouration of urine and other body fluids; staining of contact lens; crystal deposits in urinary tract. Potentially Fatal: Acute renal failure. |
||||||
Overdose Reactions |
Symptoms: Methaemoglobinaemia, haemolytic anaemia, skin pigmentation, renal and hepatic impairment. Treatment: Use methylene blue for methaemoglobinaemia. | ||||||
Lab Interactions |
May interfere with urine ketone and protein tests. May delay reactions with glucose oxidase reagents. May occasionally cause false-positive tests with Tes-Tape. | ||||||
Mechanism of Actions |
Phenazopyridine is an azo dye that exerts an analgesic effect in the urinary tract. Absorption: Absorbed from the GI tract (oral). Excretion: Via urine (65% as unchanged drug; 18% as paracetamol). |
||||||
Administration |
Should be taken with food. (Take after meals.) |
||||||
ATC Classification |
G04BX06 - phenazopyridine ; Belongs to the class of other urologicals. | ||||||
Available As |
|
Phenazopyridine
Post Review about Phenazopyridine Click here to cancel reply.
Phenazopyridine Containing Brands
Phenazopyridine is used in following diseases
Drug - Drug Interactions of Phenazopyridine
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.